Huize Holding Limited (HUIZ)
NASDAQ: HUIZ
· Real-Time Price · USD
2.19
-0.07 (-3.10%)
At close: May 15, 2025, 3:59 PM
2.19
0.00%
After-hours: May 15, 2025, 04:00 PM EDT
Huize Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Accident and Health Insurance Product Line Revenue | 136.85M | 101.04M | 62.18M | 61.49M | 49.32M | 79.53M |
| Accident and Health Insurance Product Line Revenue Growth | +35.44% | +62.48% | +1.13% | +24.68% | -37.99% | n/a |
| Health Insurance Product Line Revenue | 1.06B | 1.04B | 1.05B | n/a | n/a | 902.6M |
| Health Insurance Product Line Revenue Growth | +1.29% | -0.28% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 100.46M | 75.4M | 96.49M | 66.84M | 49.19M | 70.62M | 94.42M | 89.81M | 80.42M | 99.51M | 94.27M | 112.18M | 168.34M | 130.57M | 118.25M | 131.04M | 108.78M | 88.33M | 91.59M | 91.94M | 96.35M | 70.85M | 112.01M | 47.27M | 47.3M | 30.92M | 29.31M | 29.31M |
| Selling, General, and Administrative Revenue Growth | +33.24% | -21.86% | +44.37% | +35.88% | -30.35% | -25.21% | +5.14% | +11.67% | -19.18% | +5.56% | -15.97% | -33.36% | +28.93% | +10.42% | -9.76% | +20.46% | +23.15% | -3.56% | -0.38% | -4.57% | +35.99% | -36.75% | +136.94% | -0.06% | +52.97% | +5.50% | 0.00% | n/a |
| Research and Development Revenue | 15.89M | 14.03M | 18.1M | 14.38M | 18.24M | 14.3M | 22M | 18.31M | 16.89M | 16.36M | 24.31M | 23.34M | 46.07M | 29.83M | 25.74M | 18.83M | 15.84M | 11.48M | 10.63M | 11.19M | 11.82M | 8.1M | 7.49M | 6.41M | 7.33M | 5.58M | 6.02M | 6.02M |
| Research and Development Revenue Growth | +13.28% | -22.51% | +25.86% | -21.15% | +27.49% | -34.99% | +20.16% | +8.41% | +3.23% | -32.70% | +4.16% | -49.33% | +54.44% | +15.88% | +36.69% | +18.87% | +38.03% | +8.01% | -5.01% | -5.40% | +45.97% | +8.14% | +16.79% | -12.53% | +31.44% | -7.26% | 0.00% | n/a |
| Sales and Marketing Revenue | 58.12M | 43.27M | 46.83M | 44.2M | -118.11M | 49.13M | 57.34M | 56.28M | 41.81M | 56.4M | 59.54M | 73.92M | 112.35M | 83.4M | 77.85M | 76.98M | 71.51M | 57.86M | 48.12M | 52.95M | 61.81M | 40.2M | 33.72M | 28.93M | 31.45M | 23.65M | 19.76M | 19.76M |
| Sales and Marketing Revenue Growth | +34.30% | -7.58% | +5.93% | -137.43% | -340.41% | -14.32% | +1.89% | +34.59% | -25.86% | -5.28% | -19.46% | -34.21% | +34.72% | +7.12% | +1.14% | +7.65% | +23.60% | +20.24% | -9.13% | -14.33% | +53.76% | +19.21% | +16.59% | -8.01% | +32.97% | +19.68% | 0.00% | n/a |